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Abstract
Background: Adult mesenchymal stem cells (MSCs) derived from adipose tissue have the capacity to differentiate into 
mesenchymal as well as endodermal and ectodermal cell lineage in vitro. We characterized the multipotent ability of 
human adipose tissue-derived stem cells (hADSCs) as MSCs and investigated the neural differentiation potential of 
these cells.
Results: Human ADSCs from earlobe fat maintained self-renewing capacity and differentiated into adipocytes, 
osteoblasts, or chondrocytes under specific culture conditions. Following neural induction with bFGF and forskolin, 
hADSCs were differentiated into various types of neural cells including neurons and glia in vitro. In neural differentiated-
hADSCs (NI-hADSCs), the immunoreactivities for neural stem cell marker (nestin), neuronal markers (Tuj1, MAP2, NFL, 
NFM, NFH, NSE, and NeuN), astrocyte marker (GFAP), and oligodendrocyte marker (CNPase) were significantly increased 
than in the primary hADSCs. RT-PCR analysis demonstrated that the mRNA levels encoding for ABCG2, nestin, Tuj1, 
MAP2, NFL, NFM, NSE, GAP43, SNAP25, GFAP, and CNPase were also highly increased in NI-hADSCs. Moreover, NI-
hADSCs acquired neuron-like functions characterized by the display of voltage-dependent tetrodotoxin (TTX)-
sensitive sodium currents, outward potassium currents, and prominent negative resting membrane potentials under 
whole-cell patch clamp recordings. Further examination by RT-PCR showed that NI-hADSCs expressed high level of 
ionic channel genes for sodium (SCN5A), potassium (MaxiK, Kv4.2, and EAG2), and calcium channels (CACNA1C and 
CACNA1G), which were expressed constitutively in the primary hADSCs. In addition, we demonstrated that Kv4.3 and 
Eag1, potassium channel genes, and NE-Na, a TTX-sensitive sodium channel gene, were highly induced following 
neural differentiation.
Conclusions: These combined results indicate that hADSCs have the same self-renewing capacity and multipotency 
as stem cells, and can be differentiated into functional neurons using bFGF and forskolin.
Background
Stem cell-based therapies for the repair and regeneration
of various tissues and organs offer a paradigm shift that
may lead to alternative therapeutic solutions for a num-
ber of diseases. The emerging field of regenerative medi-
cine requires reliable sources of stem cells, biomaterial
scaffolds and cytokine growth factors. A stem cell is char-
acterized by its ability to self-renew and to differentiate
along multiple lineage pathways. The multi-lineage
potentials of embryonic stem cells (ESCs) and adult stem
cells from bone marrow have been extensively docu-
mented [1-4]. Although ESCs have been isolated from
humans and have enormous potential, their use in thera-
peutics is restricted by ethical and political issues [5,6].
Compared to ESCs, adult stem cells have diminished self-
renewal capability and multipotency. By nature, however,
adult stem cells are immunocompatible and there are no
ethical issues related to their use. The advantage of using
mesenchymal stem cells (MSCs) over other cell types is
the ability to take advantage of their autologous proper-
ties [7-11]. MSCs can easily be obtained from the
patient's own tissue, including bone marrow, adipose tis-
sue, cartilage, synovium, periosteum, muscle, and pala-
tine tonsil and expanded vigorously until the tissues
differentiate into specific cell lineages [12-21].
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Neural tissue is understood to have a limited capacity
for repair after injury, and adult neurogenesis is limited to
selected regions of the brain, including the hippocampus,
the subventricular zone, and the olfactory system [22,23].
Therefore, a broad spectrum of cells capable of neuronal
differentiation is required for cell replacement therapies.
Adult peripheral tissues may be an alternative source of
stem and progenitor cells. For example, a number of stud-
ies have shown that adult bone marrow contains a popu-
lation of mesenchymal stem cells capable of
differentiating into several lineages, including neuronal
and glial tissues [2,13,24-29]. However, bone marrow pro-
curement is extremely painful for patients and yields low
numbers of harvested cells.
Adipose tissue is emerging as a source of stem cells
obtained by less invasive methods including lipoaspira-
tion, and in larger quantities than bone marrow. Adipose
tissue, like bone marrow, is derived from the embryonic
mesoderm and contains a heterogeneous stromal cell
population that includes mature adipocytes, preadipo-
cytes, fibroblasts, vascular smooth muscle cells, endothe-
lial cells, monocyte/macrophages, and lymphocytes [30].
Adipose tissue-derived stem cells (ADSCs) are self-
renewing and can differentiate along several mesenchy-
mal tissue lineages, including adipocytes, osteoblasts,
myocytes, chondrocytes, endothelial cells, and cardio-
myocytes [14,31-35]. Since human adipose tissue is ubiq-
uitous and easily obtained in large quantities under local
anesthesia with little patient discomfort, it may present
an alternative source of stem cells for mesenchymal tissue
regeneration and engineering.
Recent studies report that ADSCs can also be induced
into neuron- or glia-like cells in vitro [12,20,36-40], but
whether MSCs can actually differentiate into neurons and
glia remains controversial [41,42]. The neuron-like mor-
phology and immunocytochemical expression for neural
markers in transdifferentiated bone marrow-derived
MSCs under culture or in vivo conditions may be due to
cell fusion [43-45]. On the contrary, some investigators
have demonstrated that neural differentiation is induced
independently of cell fusion [46], indicating either that
MSCs have an intrinsic ability for differentiation beyond
their organ of residence or that MSC differentiation
potential can be reprogrammed toward specific cell lin-
eages by exogenous cues [47]. These results imply that
the capacity of ADSCs for neural differentiation should
be evaluated functionally and morphologically.
This study aimed to examine whether neurally-induced
hADSCs (NI-hADSCs) displayed the functional charac-
teristics of neural cells. We have characterized the multi-
potent capacity of hADSCs isolated from earlobe fat and
investigated the differentiation potential of stem cells into
neural cells in the presence of bFGF and forskolin, which
are known to enhance the neuronal differentiation of
bone marrow-derived MSCs [26] over two weeks. We
identified that NI-hADSCs displayed voltage-dependent
and TTX-sensitive sodium currents, which are a func-
tional hallmark of neurons, and expressed high levels of
ionic channel genes, which are important in neural func-
tion.
Results
Isolation and characterization of adipose tissue-derived 
stem cells
Human mesenchymal stem cells were isolated from ear-
lobe fat according to their adherence to culture dishes
c o n t a i n i n g  D M E M  s u p p l e m e n t e d  w i t h  1 0 %  F B S .  T h e
cells were expanded after plating and grown to conflu-
ence. Approximately four weeks into the culture, cells
became more uniform and grew in a monolayer with typ-
ical fibroblast-like morphology (Figure 1a). The prolifera-
tion of human adipose tissue-derived stem cells
(hADSCs) remained consistent up until the 15th passage.
To clarify the isolated hADSCs, we performed FACS
analysis with various cell surface markers, including
MSC-specific cell type markers and hematopoietic stem
cell markers (Table 1). As shown in Figure 1b, more than
95% of the adipose tissue-derived hMSCs expressed
MSC-specific markers, including CD13, CD44 (endo-
glin), CD90 (Thy-1), and CD166, but did not express
markers for hematopoietic stem cells, including CD14,
CD34, and CD45. Thus, hADSCs in this experiment
appeared to be MSCs.
Pluripotent capability of hADSCs
To determine whether hADSCs are pluripotent and able
to differentiate into various cell types in vitro, hADSCs
were cultured in selection media. Human ADSCs did not
spontaneously differentiate during culture expansion.
The differentiation of hADSCs into adipocytes, osteo-
blasts, and chondrocytes were also confirmed by specific
staining and RT-PCR analysis (Figure 2). After one week
of the adipogenic culture medium culture, more than 90%
of the cells differentiated into lipid-laden cells that were
stained with oil-red O. Lipoprotein lipase was markedly
expressed in adipogenic cultured cells (Figure 2a). After
two weeks of the osteogenic medium culture, the cells
differentiated into osteoblasts, which were confirmed
with strong alkaline phosphatase staining. The RNA
expression of osteopontin in osteogenic cultured cells
was higher than that of the control cells. Parathyroid hor-
mone (PTH) receptor was also expressed in osteogenic
cultured hADSCs, indicating differentiation into osteo-
blasts (Figure 2b). Differentiation of hADSCs into chon-
drocytes was determined by staining with Alcian blue,
which identifies the proteoglycan extracellular matrix, a
specific component of cartilage tissues. Compared to
expression in the control cells, the relative RNA expres-Jang et al. BMC Cell Biology 2010, 11:25
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sion of periecan and collagen type II in chondrogenic cul-
tured cells increased significantly (Figure 2c). These
results demonstrate that hADSCs have an intrinsic plas-
ticity regarding differentiation into various mesodermal
lineage cells.
Neural differentiation of hADSCs in vitro
For neural induction, hADSCs were incubated with
growth medium supplemented with bFGF for seven days,
and then incubated in DMEM with forskolin for the next
seven days. In neurally differentiated hADSCs, immuno-
Figure 1 Isolation and characterization of hADSCs. a, Human ADSCs were isolated from fat tissue according to their adherence to culture dishes. 
Under phase contrast, hADSCs are spindle-shaped after seven days in culture. Scale bars measure 50 μm. b, Human ADSCs were labeled with FITC-
conjugated antibodies specific to CD14, CD34, and CD45. Human ADSCs were labeled with PE-conjugated antibodies specific to CD13, CD44, CD90, 
and CD166. Surface phenotype was analyzed by FACS. Open histograms refer to control immunoglobulins and colored histograms refer to specific 
antibodies. Primary hADSCs expressed MSC specific markers including CD13 (+), CD44 (+), CD90 (+), and CD166 (+), but did not express hematopoietic 
stem cell markers including CD14 (-), CD34 (-), and CD45 (-).Jang et al. BMC Cell Biology 2010, 11:25
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reactivities for neural stem cell markers (nestin), neu-
ronal markers (Tuj1, MAP2, NFL, NFM, NFH, NSE, and
NeuN), synaptic markers (GAP43 and SNAP25), astro-
cyte marker (GFAP), and oligodendrocyte marker
(CNPase) were very high when grown in the presence of
bFGF and forskolin supplements (Figure 3a, 3b). After
neural differentiation, the majority of NI-hADSCs exhib-
ited distinct bipolar or multipolar morphologies with
branched processes, which was well visualized by the
immunocytochemistry of the somatodendritic marker,
MAP2, and the axonal marker, GAP43 (Figure 3a). In
basal hADSCs, the portion of hADSCs expressing cell
type specific markers was very low. Marker-positive cells
increased considerably with neural supplements. Follow-
ing terminal differentiation with bFGF and forskolin, a
large number of neural marker-positive neurons were
observed in cultures when compared with that of GFAP-
positive astrocytes and CNPase-positive oligodendro-
cytes (Figure 3b).
Reverse-transcription polymerase chain reaction analy-
sis was used to monitor the extent of neural differentia-
tion in mRNA levels of the stem cells. In NI-hADSCs,
mRNA levels encoding for ABCG2, a neural stem cell
marker, nestin, Tuj1, MAP2, NFL, NFM, NSE, GAP43,
SNAP25, GFAP, and CNPase were higher compared with
primary hADSCs (Figure 3c, 3d).
To assess whether NI-hADSCs were differentiated into
functional neurons, electrophysiological properties were
tested in basal hADSCs and following neural differentia-
tion using the patch clamp technique in whole-cell con-
figuration. Primary hADSCs grown in the regular media
in the absence of bFGF and forskolin were quiescent,
exhibiting virtually no sodium current (n = 24, data not
shown), which is responsible in both initiation and propa-
gation of neural action potentials throughout the nervous
system. However, following differentiation with bFGF
and forskolin for two weeks, more than 75% of the NI-
hADSCs expressed prominent voltage-dependent
sodium currents up to 1.2 nA (18 of 24 cells). The mean
peak amplitude of voltage-dependent sodium currents at
-20 mV was -605 ± 36 pA (n = 18, Figure 4a). Sodium cur-
rents were blocked by 100 nM tetrodotoxin (TTX). Along
with sodium current induction, hADSCs grown with dif-
ferentiation factors demonstrated sustained outward cur-
rents, which exhibited voltage-dependence and kinetic
characteristics for delayed rectifier potassium currents
(Figure 4b). Under current clamp conditions, the resting
membrane potential of neurally differentiated hADSC (-
58.58 ± 8.46 mV, n = 24) was recorded to be significantly
more negative than that of control hADSCs (-15.47 ± 5.13
mV, n = 24; P < 0.001, Fig. 4c).
In addition to functional studies, mRNA expression for
ion channels related to outward and inward currents was
investigated in primary- and NI-hADSCs with RT-PCR
using specific primers (Table 2). In ADSCs, ion channel
protein or gene expression has not yet been reported. The
primary hADSCs expressed MaxiK (responsible for
human large-conductance, voltage- and calcium-depen-
dent K+  channel), Kv1.4 and Kv4.2 (human voltage-
dependent K+ channel), Eag2 (human ether-á-go-go K+
channel), SCN5A (TTX-insensitive Na+  channel),
CACNA1C (human voltage-dependent L-type Ca2+ chan-
nel, alpha 1C subunit), and CACNA1G (human voltage-
dependent T-type Ca2+ channel, alpha 1G subunit) con-
stitutively. However, primary hADSCs did not express
Kv4.3 (human voltage-dependent K+  channel), Eag1
Table 1: Phenotypic analysis of hMSCs with FACS
Antigen Description (+)/(-)
CD13 Bone marrow stromal cell marker (+)
CD44 Endoglin receptor (+)
CD90 (Thy-1) Endothelial cell marker (+)
CD166 Cell adhesion molecule (+)
CD14 Lipopolysaccharide receptor (-)
CD34 Hematopoietic progenitor cell marker (-)
CD45 Hematopoietic progenitor cell marker (-)Jang et al. BMC Cell Biology 2010, 11:25
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(human ether-á-go-go K+ channel), or NE-Na (TTX-sen-
sitive Na+ channel). Following neural differentiation with
bFGF and forskolin, the gene expression levels of MaxiK,
Kv4.2, Eag2, SCN5A, CACNA1C, and CACNA1G in NI-
hADSCs were significantly higher than in the primary
hADSCs (Figure 4d, 4e). Furthermore NI-hADSCs
expressed Kv4.3, Eag1, and NE-Na. These results indicate
that the hADSCs were effectively developed into func-
tional neuron-like cells and thereby expressed neuron-
specific phenotypes after being differentiated in vitro.
Discussions
Our results demonstrate that ADSCs isolated from
human earlobe fat express MSC-specific markers and can
be differentiated into neural cells via bFGF- and forsko-
lin-dependent pathways. In addition, NI-hADSCs have
neural markers and functional neuron-like characteris-
tics.
In the present study, the phenotypic expression of
hADSCs is consistent over culture passages and the mor-
phological features are the same as those previously
reported [12,34,48,49]. Adipose tissue-derived stem cells
are understood to express surface markers of CD9, CD10,
CD13, CD29, CD44, CD49d, CD49e, CD54, CD55, CD59,
CD73, CD90, CD105, CD146, CD166, and STRO-1, and
lack hematopoietic lineage markers CD11b, CD14, CD19,
CD34, and CD45 [20,34,50-53]. The hADSCs expressed
MSC-specific cell type markers including CD13, CD44,
CD90, and CD166, however, did not express CD14,
CD34, and CD45 indicating that hADSCs in this study
were of mesenchymal origin. Adipose tissue-derived stem
cells also seem to possess the capacity to differentiate into
multiple mesodermal lineages such as bone, fat, and car-
tilage [31,34]. The current study supports this hypothesis,
characterizing the expression of multiple lineage-specific
genes and proteins including adipocytes, osteoblasts, and
chondrocytes. This observation has led us to speculate
that adipose tissue may be a valuable source of mesoder-
mal stem cells.
Figure 2 Investigation of the multipotent capacity of hADSCs using immunostaining and RT-PCR analysis. a, Cells were cultured for one week 
in selection media specifically designed for adipogenic differentiation. Adipogenic differentiation is shown with oil-red O staining and RT-PCR analysis 
for lipoprotein lipase. b, Cells were cultured for two weeks in selection media specifically designed for osteogenic differentiation. Osteogenic differ-
entiation is shown with alkaline phosphatase staining and RT-PCR analysis for osteopontin and PTH receptor. c, Cells were cultured for three weeks in 
selection media specifically designed for chondrogenic differentiation. Chondrogenic differentiation is shown with Alcian blue staining and RT-PCR 
analysis for periecan and collagen type II. Scale bars measure 50 μm. GAPDH was used as a control. The intensity of each gene was normalized to 
GAPDH and these results were repeated at least five times. * P < 0.05, ** P < 0.01 compare with the primary hADSCs.Jang et al. BMC Cell Biology 2010, 11:25
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Reports indicate that the neural differentiation of
ADSCs is achieved with different experimental protocols,
Protocols include using chemical agents like β-mercapto-
ethanol[34,35], a mix of valproic acid, butylated
hydroxyanisole, insulin, hydrocortisone [38,39,54], azacy-
tidine [55,56], or a cocktail of isobutylmethylxanthine,
indomethacin, and insulin [48,57,58]. A mixture of glial
growth factors [36], a mixture including bFGF and plate-
let-derived growth factor [59], or brain-derived neu-
rotrophic factor (BDNF) with retinoic acid [12] also
evoked the neural induction of ADSCs in vitro. In addi-
tion, rodent ADSCs are differentiated into Schwann cell-
like cells by a procedure that involves making floating
neurospheres [40]. In bone marrow-derived MSCs, neu-
ral differentiation was induced via transfection of
proneural genes [25], treatment with bFGF, forskolin and
ciliary neurotrophic factor (CNTF) [9] or co-culture with
neural cells [2,46]. In the present study, we used bFGF
and forskolin to induce the neural differentiation of hAD-
SCs because bFGF is known to generate neural precursor
cells with a greater capacity for neuronal differentiation
[9,26,60]. Contrary to bFGF, epidermal growth factor and
cilliary neurotrophic factor are reported to restrict astro-
cyte lineages. Forskolin is a commonly used agent to
increase the intracellular levels of cyclic adenosine mono-
phosphate (cAMP) by activating the enzyme adenylyl
cyclase. Furthermore, forskolin is reported to induce the
neuron-like morphology and expression of NSE, NFH,
and Tuj1 in human MSCs cultured in serum-free condi-
tions [61,62]. Our experiments demonstrate that NI-
hADSCs express increased immunoreactivities for neu-
ronal markers Tuj1, MAP2, NFL, NFM, NFH, NSE,
NeuN, GAP43, and SNAP25, as well as the increased
mRNA expression of Tuj1, MAP2, NFL, NFM, NSE,
GAP43, and SNAP25 compared to primary hADSCs (Fig-
ure 3), indicating that hADSCs differentiate into neural
cells via bFGF and forskolin-mediated differentiation.
Much like neuronal cells derived from other MSCs or
embryonic stem cells [63,64], in vitro-transdifferentiated
hADSCs also exhibited neuronal cell properties.
According to previous reports about neurogenic differ-
entiation, ADSCs exhibit neuron-like morphology and
express several proteins and genes consistent with the
neuronal phenotype [20,35,54,57-59,65]. However, reli-
ance on neural marker expression as an indicator of neu-
rally differentiated MSCs has become unreliable because
Figure 3 Analysis of cell type-specific markers in NI-hADSCs. Human ADSCs were induced to differentiate into neural cells in the presence of bFGF 
and forskolin over two weeks. a, Fluorescent immunocytochemistry revealed that the expression of nestin, Tuj1, MAP2, NFL, NFM, NFH, NSE, NeuN, 
GAP43, SNAP25, GFAP, and CNPase in NI-hADSCs increased more than those of primary hADSCs. Scale bars measure 50 μm. b, Immunocytochemical 
data depicts the high ratio of NI-hADSCs expression above neuronal markers. The number of positive cells was counted and the ratio of positive cells 
to nuclei was analyzed for each antigen (n = 7). c and d, RT-PCR analysis demonstrated increased mRNA expression for ABCG2, nestin, Tuj1, MAP2, NFL, 
NFM, NSE, GAP43, SNAP25, GFAP and CNPase genes. GAPDH was used as a control. The intensity of each gene was normalized to GAPDH and these 
results were repeated at least five times. * P < 0.05, ** P < 0.01 compare with the primary hADSCsJang et al. BMC Cell Biology 2010, 11:25
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undifferentiated MSCs express several neural markers at
both the mRNA and protein levels [42,66]. Adult mesen-
chymal stem cells constitutively express native immature
neural proteins (nestin and Tuj1), whereas more mature
neuronal and glial proteins (tyrosine hydroxylase, MAP2,
and GFAP) are expressed in increasing passage numbers
[67,68]. Undifferentiated ADSCs also express markers
characteristic of neural cells such as NSE, vimentin, and
NeuN [57]. In addition, inter-donor variability of expres-
sion of neural marker genes in MSC samples needs to be
considered [42]. We therefore performed electrophysio-
logical studies to investigate whether NI-hADSCs dem-
onstrate the functional properties of mature neurons.
Through patch-clamp recordings, NI-hADSCs were
identified to generate prominent TTX-sensitive voltage-
dependent sodium currents and outward potassium cur-
rents, both of which are hallmarks of mature neurons and
crucial for signal transmission in the nervous system. In
contrast to bone marrow-derived MSCs, in which combi-
nation of bFGF, forskolin, and CNTF was not sufficient to
induce voltage-dependent sodium current [9], hADSCs
expressed the sodium current by treatment of bFGF and
Figure 4 Electrophysiological and RT-PCR analyses for ion channels in NI-hADSCs. Electrophysiological features of the hADSCs demonstrated 
neuronal characteristics following neural differentiation. a, The holding potential was -80 mV and depolarizing steps were applied in mV intervals from 
-80 mV to +40 mV. Voltage-dependent sodium currents were activated from a depolarizing step of -30 mV and blocked reversibly by TTX 100 nM. The 
peak current-voltage relationship was plotted against the voltages, demonstrating the voltage-dependence of sodium currents (n = 16). b, The hAD-
SCs grown with bFGF and forskolin demonstrated sustained outward potassium currents. The peak current-voltage relationship was plotted against 
the voltages, demonstrating the voltage-dependence of potassium currents (n = 12). c, Under current clamp conditions, the resting membrane po-
tential of NI-hADSCs was more negative than that of control hADSCs grown without bFGF and forskolin (n = 16). d and e, The expression of molecular 
markers for ion channel subunits increased following neural differentiation in hADSCs. The mRNA expression of human large-conductance, voltage- 
and calcium-dependent K+ channel marker, MaxiK; voltage-dependent K+ channel marker, Kv1.4, Kv4.2 and Kv4.3; ether-á-go-go K+ channel markers, 
Eag1 and Eag2; tetrodotoxin-sensitive Na+ channel marker, NE-Na; voltage-dependent L-type Ca2+ channel, alpha 1C subunit marker, CACNA1C; volt-
age-dependent T-type Ca2+ channel, alpha 1G subunit marker, CACNA1G, and TTX-insensitive sodium channel marker, SCN5A, each increased in NI-
hADSCs. GAPDH was used as a control. The RT-PCR assay was repeated five times independently of different cells and the representative data are 
shown. The intensity of each gene was normalized to GAPDH. * P < 0.05, ** P < 0.01 compare with the primary hADSCs.Jang et al. BMC Cell Biology 2010, 11:25
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Table 2: Sequence of PCR primers
Gene Sense Antisense
Lipoprotein lipase CTTCTGTTCTAGGGAGAAAGTG TGCTGTGTAGATGAGTCTGATT
Osteopontin GAAGGACAGTTATGAAACGAGT AACATAGACATAACCCTGAAGC
PTH receptor AACTACTACTGGATTCCTGGTGG CTCCAAGATTTCTTGATCTCAG
Periecan CATAGAGACCGTCACAGCAAG ATGAACACCACACTGACAACC
Collagen type II ACGGCGAGAAGGGAGAAGTTG GGGGGTCCAGGGTTGCCATTG
ABCG2 CAAAACTTGCTGGGTAATC ACAGAAACCACACTCTGACC
Nestin CTCTGACCTGTCAGAAGAAT GACGATGACACTTACAGAAT
Tuj1 CATGGATGCCGCTCAG CAGGCAGTCGCAGTTTTCAC
MAP2 TGCCATCTTGGTGCCGA CTTGACATTACCACCTCCAGGT
NFL TCCTACTACACCAGCCATGT TCCCCAGCACCTTCAACTTT
NFM TGGGAAATGGCTCGTCATTT CTTACTGGAAGCGGCCAATT
NSE CTGATGCTGGAGTTGGATGG CCATTGATCACGTTGAAGGC
GAP43 TCCTGAGCCCTGTCTCTCCCT GCCACACTGTTTGACTTGGG
SNAP25 AGTTGGCTGATGAGTCGCTG TGAAAAGGCCACAGCATTTC
GFAP GCAGAGATGATGGAGCTCAATGACC GTTTCATCCTGGAGCTTCTGCCTCA
CNPase GGCCACGCTGCTAGAGTGCAAGAC GGTACTGGTACTGGTCGGCCATTT
MaxiK ACAACATCTCCCCCAACC TCATCACCTTCTTTCCAATTC
Kv1.4 ACGAGGGCTTTGTGAGAGAA CACGATGAAGAAGGGGTCAT
Kv4.2 ACCGTGACCCAGACATCTTC CACTGTTTCCACCACATTCG
Kv4.3 GCCTCCGAACTAGGCTTTCT CCCTGCGTTTATCAGCTCTC
EAG1 TGGATTTTGCAAGCTGTCTG GAGTCTTTGGTGCCTCTTGC
EAG2 ACATCCTGCTTTTCGATTGG CGGCTCTCTACCTGGCGTTGJang et al. BMC Cell Biology 2010, 11:25
http://www.biomedcentral.com/1471-2121/11/25
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forskolin. Furthermore, NI-hADSCs exhibited about -58
mV of resting membrane potential, indicating that they
also have functional characteristics of neurons.
Recently, Anghileri et al. reported electrophysiological
evidence of neuronal differentiation [12]. After differenti-
ation with BDNF and retinoic acid, hADSC exhibited
immunocytochemical evidence of neuronal differentia-
tion in only 57% of cells and mean peak amplitude of
approximately -189 pA for voltage-dependent Na+ cur-
rents in differentiated hADSCs. Ashjian et al. also dem-
onstrated that supplementation with
isobutylmethylxnthine (IBMX), indomethacin and insu-
lin induced transdifferentiation of human processed
lipoaspirate cells into neuron-like cells [57]. However,
they could not observe inward sodium currents. Accord-
ing to our immunocytochemical studies, our results indi-
cate that more than 80% of hADSCs appear to
differentiate into neuron-like cells under specific in vitro
culture conditions with bFGF and forskolin, and express
several proteins specific to the neuronal phenotype that
exhibit neuronal morphology (Figure 3a, 3b). Further-
more, approximately 75% of hADSCs demonstrate neural
differentiation properties under electrophysiological
study, with about -605 pA of voltage-dependent sodium
currents being recorded in NI-hADSCs. These results
suggest that bFGF and forskolin may be more effective
than BDNF, retinoic acid, IBMX, indomethacin, and insu-
lin in inducing the neural differentiation of ADSCs.
Although ADSCs have been used for years in the inves-
tigation of cell replacement therapy and differentiation,
information about ion channel expression remains
undocumented. Undifferentiated bone marrow-derived
hMSCs are known to express the TTX-sensitive sodium
channel gene (NE-Na), potassium channel genes (MaxiK,
Kv1.4, Kv4.2, Kv4.3, and Eag1) and the calcium channel
gene (CACNA1C) [56,57]. However, this study indicates
that primary hADSCs also express ion channel mRNAs,
including potassium channel genes (MaxiK, Kv1.4, Kv4.2,
and Eag2), calcium channel genes (CACNA1C and
CACN1G), and the TTX-insensitive sodium channel
gene (SCN5A), but do not exhibit the TTX-sensitive
sodium channel gene (NE-Na) and other voltage-depen-
dent potassium channel genes (Kv4.3 and Eag1) (Figure
4d). Since the primary hADSCs did not display voltage-
dependent sodium currents prior to neural differentia-
tion, gene expression results are consistent with electro-
physiological data. However, neural induction with bFGF
and forskolin increased the expression of these ion chan-
nel genes, particularly those expressed in the primary
hMSCs, and induced three novel functional ion channel
genes (NE-Na, Kv4.3, and Eag1), indicating the differenti-
ation of hADSCs towards neuronal cells. This result is an
initial finding on the expression of ionic channel genes in
both primary- and NI-hADSCs.
Conclusions
The present study demonstrates that hADSCs have the
ability to act as mesenchymal stem cells and can effec-
tively differentiate into functional neuron-like cells with
bFGF and forskolin treatment.
Methods
Preparation of hADSCs
Fat tissue from the human earlobe was obtained from
healthy donors 4-20 years of age. Informed consent was
obtained from all donors according to the Guidelines of
the Ethics Committee at Chonnam National University
Medical School. Human mesenchymal stem cells were
isolated from fat tissue samples according to the previous
report [32]. Human fat tissue was rinsed with PBS con-
taining 1% penicillin-streptomycin (Hyclone, Logan, UT,
USA), cut into small pieces, and then incubated in a solu-
tion containing 0.075% collagenase type IA (Sigma
Chemical Co., St. Louis, MO. USA) for 1 h at 37°C with
vigorous shake. The top lipid layer was removed and the
remaining liquid portion was centrifuged at 220 g for 15
min at room temperature. The pellet was treated with 160
mM NH4Cl (Sigma Chemical Co.) for 10 min to remove
red blood cells. The remaining cells were filtered through
a 40-μm nylon mesh filter (BD Falcon, Franklin Lakes, NJ,
NE-Na GCTCCGAGTCTTCAAGTTGG GGTTGTTTGCATCAGGGTCT
SCN5A CCTAATCATCTTCCGCATCC TGTTCATCTCTCTGTCCTCATC
CACNA1C AACATCAACAACGCCAACAA AGGGCAGGACTGTCTTCTGA
CACNA1G CTGCCACTTAGAGCCAGTCC TCTGAGTCAGGCATTTCACG
GAPDH CATGACCACAGTCCATGCCATCACT TGAGGTCCACCACCCTGTTGCTGTA
Table 2: Sequence of PCR primers (Continued)Jang et al. BMC Cell Biology 2010, 11:25
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USA), and plated at a density of 1 × 105 cells in a 10-cm
dish. Isolated human mesenchymal stem cells were
grown as adherent cultures in Dulbecco's modified
Eagle's medium (DMEM; Hyclone, Logan, UT, USA) sup-
plemented with 10% fetal bovine serum (FBS; Hyclone)
and 1% penicillin-streptomycin. After four weeks, cells
were grown to approximately 80% confluence in a 37°C
humidified incubator with a 5% CO2 and 95% air environ-
ment. The morphological features of the hADSCs were
the same as those previously described [12,33]. The hAD-
SCs used in the present study were from passages 3 to 7.
Fluorescence-activated cell sorting
For fluorescence-activated cell sorter (FACS) analysis,
hADSCs were harvested in trypsin containing ethylene-
diaminetetraacetic acid (Hyclone), washed twice with
phosphate-buffered saline (PBS; Amresco, Inc., Solon,
OH, USA), and stained on ice according to the manufac-
turer's recommendations with monoclonal antibodies
(BD Biosciences PharMingen™, Heidelberg, Germany),
including PE-CD13, FITC-CD14, FITC-CD34, PE-CD44,
FITC-CD45, PE-CD90, and PE-CD166. At least 10,000
events were collected and analyzed with flow cytometry
(BD FACSCalibur System, BD Biosciences Immunocy-
tometry System, Heidelberg, Germany).
Differentiation culture conditions
Adipogenic differentiation of hADSCs was induced by
growing the cells in adipocyte differentiation basal
medium containing an adipogenic supplement (Gibco
BRL, Grand Island, NY, USA) for one week. One week
following induction, cells were stained with oil-red O
(Sigma Chemical Co.). Human fat tissue was used as a
positive control. For negative controls, oil-red O was
omitted from the reaction series. To induce osteogenic
differentiation, hADSCs were cultured in an osteogenic
differentiation basal medium containing osteogenic sup-
plement (Gibco BRL). After two weeks, osteogenic differ-
entiation was evaluated with alkaline phosphatase
staining (TRACP & ALP double-stain kit, Takara Bio Inc.
Shiga, Japan). Human bone tissue was used as a positive
control. For negative controls, the substrate for alkaline
phosphatase was omitted from the reaction series. For
chondrogenic differentiation, cells were cultured for
three weeks in the presence of chondrogenic supplement
in chondrogenic differentiation basal medium (Gibco
BRL). This medium was replaced every 3-4 days for three
weeks. The development of chondrogenic differentiation
was determined by staining the medium with Alcian blue
(Sigma Chemical Co.). Human cartilage tissue was served
as a positive control. For negative controls, oil-red O was
omitted from the reaction series. To induce neural differ-
entiation, hADSCs were grown in DMEM containing 1%
FBS and supplementary 100 ng/mL basic fibroblast
growth factor (bFGF, Invitrogen Co., Carlsbad, CA, USA)
for seven days. The cells were then incubated in the pres-
ence of 10 μM forskolin (Sigma Chemical Co.) and over
the next seven days, the cells were subjected to immuno-
cytochemical, electrophysiological, and RT-PCR analy-
ses.
Reverse transcriptase-polymerase chain reaction (RT-PCR) 
analysis
To analyze the relative expression of different mRNAs,
the amount of cDNA was normalized based on signals
from the ubiquitously expressed GAPDH [69]. Total RNA
was extracted from cultured cells by using TriReagent
(Molecular Research Center, Inc., Cincinnati, OH, USA),
and 1 μg of cDNA was reverse-transcribed using a
reverse transcriptase (M-MLV, Gibco BRL) for 90 min at
42°C. PCR primer (Bioneer Co., Daejeon, Korea) pairs
were selected to discriminate between cDNA and
genomic DNA by using individual primers specific to dif-
ferent exons, when possible. The cDNA was amplified by
35 cycles of PCR (Takara Bio Inc.) using Ex-Taq poly-
merase (Takara Bio Inc.). Forward and reverse PCR oligo-
nucleotide primers selected to amplify the cDNA are
listed in Table 2. RT-PCR products were separated elec-
trophoretically on 2% agarose gels (Sigma Chemical Co.).
Immunocytochemistry
The immunocytochemical determination of cell type spe-
cific markers in hADSCs was performed as follows: Cells
were grown on poly-L-lysine-coated aclar plastic cover-
slips for 10 days, fixed for 15 min with 4% paraformalde-
hyde (PFA; Sigma Chemical Co.), and blocked for 20 min
with 0.5% Triton X-100 (Sigma Chemical Co.), which
included 10% normal goat serum (Vector Laboratories,
Inc., Burlingame, CA, USA) in PBS. Anti-nestin (1:300),
anti-neuron-specific class III β-tubulin (Tuj1, 1:300),
anti-microtubule associated protein-2 (MAP2, 1:200),
anti-neurofilament-L (NFL, 1:300), anti-neurofilament-M
(NFM, 1:300), anti-neurofilament-H (NFH, 1:300), anti-
neuron specific enolase (NSE, 1:100), anti-neuronal spe-
cific nuclear protein (NeuN, 1:300), anti-growth associ-
ated protein 43 (GAP43, 1:300), anti-synaptosome-
associated protein 25 kDa (SNAP25, 1:200), anti-glial
fibrillary acidic protein (GFAP, 1:300), or anti-2',3'-cyclic
nucleotide 3'-phosphodiesterase (CNPase, 1:100) were
then added. Primary antibodies were incubated overnight
at 4°C. After washing, Alexa 546-conjugated goat anti-
mouse antibody (Molecular Probes, Invitrogen Co., CA,
USA) was used as a secondary antibody and incubated at
room temperature for 1 h. Nuclei were stained with DAPI
for cell counting. Cells were observed using a Zeiss
LSM510 confocal microscope (Carl Zeiss, Jena, Ger-
many). All primary antibodies were purchased from
Chemicon (Chemicon, Temecula, CA, USA). Experi-Jang et al. BMC Cell Biology 2010, 11:25
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ments were performed in triplicate and the percentage of
positive cells was randomly calculated. To perform quan-
titative analysis, the numbers of positive cells was
counted on each acquired image by ImageJ1.42 (NIH),
and the ratio to the number of nuclei was analyzed for
each antigen. For negative controls, primary antibody was
omitted from the reaction series. HB1.F3 human neural
stem cells and postmortem human brain tissue were
served as positive controls for nestin and the other anti-
gens, respectively.
To stain the adipose cells with oil-red O, cells were
fixed with 4% PFA for 15 min, washed with 60% isopropa-
nol (Sigma Chemical Co.) and air-dried. A fresh 60% oil-
red O working solution was prepared from stock solution
(0.7 g oil-red O in 200 mL isopropanol) and filtered
through a 45 μM syringe filter. Cells were stained with the
working solution for 45 min and then washed five times
with distilled water. During the alkaline phosphatase
staining for osteoblasts, cells were fixed with 4% PFA for
15 min, washed with PBS, and incubated with alkaline
phosphatase (using Takara kit) for 20 min. During Alcin
blue staining for chondrocytes, cells were fixed 4% PFA
for 15 min and then incubate with 3% acetic acid. Cells
were stained with 1% Alcian blue in 3% acetic acid (pH
2.5) for 30 min and then washed with distilled water. The
cells were examined using a light microscope (Olympus
DP70, Japan).
Electrophysiology
Cells grown on coverslips for two weeks were placed in a
recording chamber on the stage of an inverted micro-
scope (Eclipse TE 2000-S, Nikon; Tokyo, Japan), and volt-
age-dependent ionic currents and resting membrane
potentials were recorded using the whole-cell patch
clamp technique [70]. Patch micropipettes having a resis-
tance of 2-4 MΩ were pulled with an electrode puller
(PP830, Narishige, Japan) from borosilicate glass capillar-
ies (G150T-3, Warner Instruments, CT, USA) and fire-
polished using a microforge (MF-790, Narishige).
Pipettes were filled with an intracellular-like solution
containing 140 mM KCl, 5 mM NaCl, 1 mM CaCl2, 10
mM HEPES, 5 mM EGTA, 2 mM Mg-ATP for the inward
Na+ currents and outward K+ currents to record. The pH
was adjusted to 7.3 with KOH and filtered before use. The
standard external solution was comprised of 140 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM glu-
cose, 10 mM HEPES. The solutions were adjusted to pH
7.3 with NaOH. Whole-cell currents were recorded at 22-
24°C using a patch-clamp amplifier (Axopatch 200B,
Axon Instruments, Foster City, CA, USA) and digitized
by an analog-to-digital interface (Digidata 1320, Axon
Instruments). Membrane currents were low-pass filtered
at 2 kHz, sampled at 50 kHz, and then stored on the hard
disk of an IBM-compatible computer using pClamp8.2
(Axon Instruments). The cells were held at -70 mV and
depolarized in 10 mV intervals between -60 and +40 mV.
The bathing or drug-containing solutions were applied to
the recording chamber with a gravity-fed perfusion sys-
tem.
Statistics
Protein and mRNA levels were quantified by measuring
the optical density of each band using computer-assisted
densitometry (NIH Image analysis program, version
1.61). All values are expressed as the mean ± SEM. The
one-way ANOVA test (Bonferroni post hoc comparison)
was used to analyze differences between groups, with P <
0.05 being considered significant.
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